Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293787090> ?p ?o ?g. }
- W4293787090 endingPage "6004" @default.
- W4293787090 startingPage "5995" @default.
- W4293787090 abstract "Aggressive large B-cell lymphoma (LBCL) has variable outcomes. Current prognostic tools use factors for risk stratification that inadequately identify patients at high risk of refractory disease or relapse before initial treatment. A model associating 2 risk factors, total metabolic tumor volume (TMTV) >220 cm3 (determined by fluorine-18 fluorodeoxyglucose positron emission tomography coupled with computed tomography) and performance status (PS) ≥2, identified as prognostic in 301 older patients in the REMARC trial (#NCT01122472), was validated in 2174 patients of all ages treated in 2 clinical trials, PETAL (Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas; N = 510) and GOYA (N = 1315), and in real-world clinics (N = 349) across Europe and the United States. Three risk categories, low (no factors), intermediate (1 risk factor), and high (2 risk factors), significantly discriminated outcome in most of the series. Patients with 2 risk factors had worse outcomes than patients with no risk factors in the PETAL, GOYA, and real-world series. Patients with intermediate risk also had significantly worse outcomes than patients with no risk factors. The TMTV/Eastern Cooperative Oncology Group-PS combination outperformed the International Prognostic Index with a positive C-index for progression-free survival and overall survival in most series. The combination of high TMTV > 220 cm3 and ECOG-PS ≥ 2 is a simple clinical model to identify aggressive LBCL risk categories before treatment. This combination addresses the unmet need to better predict before treatment initiation for aggressive LBCL the patients likely to benefit the most or not at all from therapy." @default.
- W4293787090 created "2022-08-31" @default.
- W4293787090 creator A5001202891 @default.
- W4293787090 creator A5003078312 @default.
- W4293787090 creator A5005156859 @default.
- W4293787090 creator A5006161907 @default.
- W4293787090 creator A5006705594 @default.
- W4293787090 creator A5014639728 @default.
- W4293787090 creator A5025204567 @default.
- W4293787090 creator A5026115520 @default.
- W4293787090 creator A5028150737 @default.
- W4293787090 creator A5030681199 @default.
- W4293787090 creator A5033073385 @default.
- W4293787090 creator A5049252531 @default.
- W4293787090 creator A5052597763 @default.
- W4293787090 creator A5055439790 @default.
- W4293787090 creator A5058392949 @default.
- W4293787090 creator A5062305482 @default.
- W4293787090 creator A5066749138 @default.
- W4293787090 creator A5069202689 @default.
- W4293787090 creator A5070411980 @default.
- W4293787090 creator A5079235139 @default.
- W4293787090 creator A5079749862 @default.
- W4293787090 creator A5082867129 @default.
- W4293787090 creator A5085255418 @default.
- W4293787090 creator A5091229393 @default.
- W4293787090 date "2022-11-30" @default.
- W4293787090 modified "2023-10-14" @default.
- W4293787090 title "A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma" @default.
- W4293787090 cites W1972232210 @default.
- W4293787090 cites W2018071905 @default.
- W4293787090 cites W2020789296 @default.
- W4293787090 cites W2031855605 @default.
- W4293787090 cites W2051650384 @default.
- W4293787090 cites W2056641238 @default.
- W4293787090 cites W2063691874 @default.
- W4293787090 cites W2072351874 @default.
- W4293787090 cites W2086804941 @default.
- W4293787090 cites W2102602525 @default.
- W4293787090 cites W2106421416 @default.
- W4293787090 cites W2119147717 @default.
- W4293787090 cites W2131900456 @default.
- W4293787090 cites W2133201432 @default.
- W4293787090 cites W2142724147 @default.
- W4293787090 cites W2147246240 @default.
- W4293787090 cites W2158267770 @default.
- W4293787090 cites W2275941472 @default.
- W4293787090 cites W2291210741 @default.
- W4293787090 cites W2310716991 @default.
- W4293787090 cites W2326948361 @default.
- W4293787090 cites W2507512417 @default.
- W4293787090 cites W2598700764 @default.
- W4293787090 cites W2605767476 @default.
- W4293787090 cites W2742627598 @default.
- W4293787090 cites W2762450632 @default.
- W4293787090 cites W2784752532 @default.
- W4293787090 cites W2788380546 @default.
- W4293787090 cites W2797584152 @default.
- W4293787090 cites W2800320119 @default.
- W4293787090 cites W2801763724 @default.
- W4293787090 cites W2888203943 @default.
- W4293787090 cites W2927995861 @default.
- W4293787090 cites W2989546915 @default.
- W4293787090 cites W3002263815 @default.
- W4293787090 cites W3016044607 @default.
- W4293787090 cites W3016807157 @default.
- W4293787090 cites W3107716360 @default.
- W4293787090 cites W3134205746 @default.
- W4293787090 cites W3199011255 @default.
- W4293787090 cites W4205736005 @default.
- W4293787090 cites W4220761695 @default.
- W4293787090 doi "https://doi.org/10.1182/bloodadvances.2021006923" @default.
- W4293787090 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36044385" @default.
- W4293787090 hasPublicationYear "2022" @default.
- W4293787090 type Work @default.
- W4293787090 citedByCount "4" @default.
- W4293787090 countsByYear W42937870902023 @default.
- W4293787090 crossrefType "journal-article" @default.
- W4293787090 hasAuthorship W4293787090A5001202891 @default.
- W4293787090 hasAuthorship W4293787090A5003078312 @default.
- W4293787090 hasAuthorship W4293787090A5005156859 @default.
- W4293787090 hasAuthorship W4293787090A5006161907 @default.
- W4293787090 hasAuthorship W4293787090A5006705594 @default.
- W4293787090 hasAuthorship W4293787090A5014639728 @default.
- W4293787090 hasAuthorship W4293787090A5025204567 @default.
- W4293787090 hasAuthorship W4293787090A5026115520 @default.
- W4293787090 hasAuthorship W4293787090A5028150737 @default.
- W4293787090 hasAuthorship W4293787090A5030681199 @default.
- W4293787090 hasAuthorship W4293787090A5033073385 @default.
- W4293787090 hasAuthorship W4293787090A5049252531 @default.
- W4293787090 hasAuthorship W4293787090A5052597763 @default.
- W4293787090 hasAuthorship W4293787090A5055439790 @default.
- W4293787090 hasAuthorship W4293787090A5058392949 @default.
- W4293787090 hasAuthorship W4293787090A5062305482 @default.
- W4293787090 hasAuthorship W4293787090A5066749138 @default.
- W4293787090 hasAuthorship W4293787090A5069202689 @default.
- W4293787090 hasAuthorship W4293787090A5070411980 @default.
- W4293787090 hasAuthorship W4293787090A5079235139 @default.